Fig. 2

Kaplan-Meier curves for continuation of endocrine therapy among (a) all test-eligible women, (b) by tested status, and (c) by RS category
Kaplan-Meier curves for continuation of endocrine therapy among (a) all test-eligible women, (b) by tested status, and (c) by RS category